MEDIQON Group AG (MDCKF) Stock Statistics & Valuation Metrics
Total Valuation
MEDIQON Group AG has a market cap or net worth of $1.30B. The enterprise value is $1.19B.
- Market Cap
- $1.30B
- Enterprise Value
- $1.19B
Share Statistics
MEDIQON Group AG has 25,364,090 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,364,090
- Owned by Insiders
- ―
- Owned by Institutions
- 0.96%
Financial Efficiency
MEDIQON Group AG’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -7.74%.
- Return on Equity (ROE)
- -0.13
- Return on Assets (ROA)
- -0.04
- Return on Invested Capital (ROIC)
- -7.74%
- Return on Capital Employed (ROCE)
- -0.08
- Revenue Per Employee
- 139.08K
- Profits Per Employee
- -22.80K
- Employee Count
- 1,300
- Asset Turnover
- 0.27
- Inventory Turnover
- 23.05
Valuation Ratios
The current PE Ratio of MEDIQON Group AG is -31.34. MEDIQON Group AG’s PEG ratio is -0.31.
- PE Ratio
- -31.34
- PS Ratio
- 5.07
- PB Ratio
- 5.37
- Price to FCF
- 157.73
- Price to Operating Cash Flow
- 122.44
- PEG Ratio
- -0.31
Income Statement
In the last 12 months, MEDIQON Group AG had revenue of 180.80M and earned -29.65M in profits. Earnings per share was -1.24.
- Revenue
- 180.80M
- Gross Profit
- -12.21M
- Operating Income
- -49.96M
- Pretax Income
- -38.05M
- Net Income
- -29.65M
- EBITDA
- -2.40M
- Earnings Per Share (EPS)
- -1.24
Cash Flow
In the last 12 months, operating cash flow was 8.91M and capital expenditures -1.99M, giving a free cash flow of 6.92M billion.
- Operating Cash Flow
- 8.91M
- Free Cash Flow
- 6.92M
- Free Cash Flow per Share
- 0.29
Dividends & Yields
MEDIQON Group AG pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.63%
- Earnings Yield
- -3.18%
Stock Price Statistics
- Beta
- 0.09
- 52-Week Price Change
- 18.04%
- 50-Day Moving Average
- 49.89
- 200-Day Moving Average
- 42.34
- Relative Strength Index (RSI)
- 52.72
- Average Volume (3m)
- 5,571
Important Dates
MEDIQON Group AG upcoming earnings date is May 27, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 09, 2026
- Next Earnings Date
- May 27, 2027
- Ex-Dividend Date
- ―
Financial Position
MEDIQON Group AG as a current ratio of 4.93, with Debt / Equity ratio of 110.75%
- Current Ratio
- 4.93
- Quick Ratio
- 4.66
- Debt to Market Cap
- 0.25
- Net Debt to EBITDA
- -58.96
- Interest Coverage Ratio
- -3.15
Taxes
In the past 12 months, MEDIQON Group AG has paid 2.17M in taxes.
- Income Tax
- 2.17M
- Effective Tax Rate
- -0.06
Enterprise Valuation
MEDIQON Group AG EV to EBITDA ratio is 76.23, with an EV/FCF ratio of 181.20.
- EV to Sales
- 5.83
- EV to EBITDA
- 76.23
- EV to Free Cash Flow
- 181.20
- EV to Operating Cash Flow
- 140.66
Balance Sheet
MEDIQON Group AG has $115.41M in cash and marketable securities with $265.58M in debt, giving a net cash position of -$150.17M billion.
- Cash & Marketable Securities
- $115.41M
- Total Debt
- $265.58M
- Net Cash
- -$150.17M
- Net Cash Per Share
- -$5.92
- Tangible Book Value Per Share
- -$6.90
Margins
Gross margin is -2.37%, with operating margin of -21.29%, and net profit margin of -16.15%.
- Gross Margin
- -2.37%
- Operating Margin
- -21.29%
- Pretax Margin
- -23.27%
- Net Profit Margin
- -16.15%
- EBITDA Margin
- 7.65%
- EBIT Margin
- -21.29%
Analyst Forecast
The average price target for MEDIQON Group AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 75.13%
- EPS Growth Forecast
- -57.58%
Scores
- Smart Score
- 6
- AI Score
- ―
